ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 02 Aug 2021
Last Applicant/ Owned by
430 E. 29th Street, 14th Floor
New York
NY
10016
Serial Number
87501342 filed on 22nd Jun 2017
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LAGOPVI
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, name Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Mark Details
Serial Number
No 87501342
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Aug 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 02th Aug 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 13th Jan 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Jan 2021 | EXTENSION 5 GRANTED |
| 12th Jan 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 28th Dec 2020 | EXTENSION 5 FILED |
| 28th Dec 2020 | TEAS EXTENSION RECEIVED |
| 30th Jun 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th Jun 2020 | EXTENSION 4 GRANTED |
| 26th Jun 2020 | EXTENSION 4 FILED |